Page last updated: 2024-11-06

mitomycin and Meningitis, Pneumococcal

mitomycin has been researched along with Meningitis, Pneumococcal in 1 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cabellos, C1
Guillem, L1
Pelegrin, I1
Tubau, F1
Ardanuy, C1
Gudiol, F1
Ariza, J1
Viladrich, PF1

Other Studies

1 other study available for mitomycin and Meningitis, Pneumococcal

ArticleYear
Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
    Antimicrobial agents and chemotherapy, 2022, 12-20, Volume: 66, Issue:12

    Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Cohort Studies; Humans; Meningitis,

2022